A New Therapeutic Agent for Cystinuria
暂无分享，去创建一个
[1] S. Sugawara,et al. Phase I Study of N-(2-Mercapto-2-methylpropiony1)-L-cysteine (SA96).(I) Single Administration Study , 1985 .
[2] 進 田口,et al. 5-FUおよび5'-DFURの至適投与法について , 1985 .
[3] S. Yachiku,et al. Conservative treatment of cystine calculi: effect of oral alpha-mercaptopropionylglycine on cystine stone dissolution and on prevention of stone recurrence. , 1982, The Journal of urology.